These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8469665)

  • 1. [Sclerodermatous cutaneous reaction of graft vs host disease treated with thalidomide].
    Pédailles S; Troussard X; Launay V; Bazin A; Sentias C; Surbled M
    Presse Med; 1993 Jan 2-16; 22(1):37. PubMed ID: 8469665
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.
    Moreno-Romero JA; Fernández-Avilés F; Carreras E; Rovira M; Martínez C; Mascaró JM
    Arch Dermatol; 2008 Sep; 144(9):1106-9. PubMed ID: 18794453
    [No Abstract]   [Full Text] [Related]  

  • 3. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of severe sclerodermatous chronic graft-versus-host disease: exposure to cement containing abundant silica may have been a relevant factor in scleroderma-like skin changes.
    Uenishi T; Sugiura H
    J Dermatol; 2005 May; 32(5):413-5. PubMed ID: 16043910
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
    Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
    Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.
    Nair V; Sharma A; Ghosh I; Arora S; Sahai K; Dutta V
    J Assoc Physicians India; 2005 Nov; 53():988-90. PubMed ID: 16515241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the tongue after bone marrow transplant and graft-versus-host disease: a case report and review of the literature.
    Byun JH; Park BW; Kim JR; Lee GW; Lee JH
    J Oral Maxillofac Surg; 2008 Jan; 66(1):144-7. PubMed ID: 18083430
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide.
    Staumont-Sallé D; Magro L; Piette F; Thomas P; Jouet JP; Catteau B
    Acta Derm Venereol; 2003; 83(4):302-3. PubMed ID: 12926809
    [No Abstract]   [Full Text] [Related]  

  • 9. Sclerodermatous changes of chronic graft-versus-host-disease treated with puva.
    Woscoff A; Ruíz Lascano A; De Pablo AB; Robinson A
    Int J Dermatol; 1996 Sep; 35(9):656-8. PubMed ID: 8876297
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone marrow transplantation for chronic myelogenous leukemia].
    Imanari A; Shibata A
    Nihon Rinsho; 1990 Sep; 48(9):2087-91. PubMed ID: 2232214
    [No Abstract]   [Full Text] [Related]  

  • 11. Bowel permeability tests and acute graft-versus-host disease.
    Fegan CD; Whitaker JA
    Bone Marrow Transplant; 1995 May; 15(5):814-6. PubMed ID: 7670415
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
    Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
    Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
    [No Abstract]   [Full Text] [Related]  

  • 13. CT and MRI findings in sclerodermatous chronic graft vs. host disease.
    Dumford K; Anderson JC
    Clin Imaging; 2001; 25(2):138-40. PubMed ID: 11483427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired neuromyotonia after bone marrow transplantation.
    Liguori R; Vincent A; Avoni P; Valentino ML; D'Alessandro R; Zaccaria A; Bandini G; Montagna P
    Neurology; 2000 Mar; 54(6):1390-1. PubMed ID: 10746621
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
    Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
    Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe cutaneous ulceration following treatment with thalidomide for GVHD.
    Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K
    Bone Marrow Transplant; 2001 Jan; 27(2):229-30. PubMed ID: 11281398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual presentation of chronic graft-versus-host disease in an unrelated bone marrow transplantation.
    LeVeque FG
    Oral Surg Oral Med Oral Pathol; 1990 May; 69(5):581-4. PubMed ID: 2333210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for chronic myelogenous leukemia.
    Champlin R
    Curr Opin Oncol; 1990 Apr; 2(2):258-62. PubMed ID: 2095240
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous pemphigoid associated with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Delbaldo C; Rieckhoff-Cantoni L; Helg C; Saurat JH
    Bone Marrow Transplant; 1992 Oct; 10(4):377-9. PubMed ID: 1422495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barre syndrome--pathological connection with GvHD after allogeneic bone marrow transplantation.
    Nasilowska-Adamska B; Lysiak Z; Halaburda K; Szczepinski A; Ejduk A; Marianska B
    Ann Transplant; 2006; 11(3):10-1. PubMed ID: 17494293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.